de Haan L - Search Results

1

The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme.

Gayer-Anderson C, Jongsma HE, Di Forti M, Quattrone D, Velthorst E, de Haan L, Selten JP, Szöke A, Llorca PM, Tortelli A, Arango C, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Parellada M, Tarricone I, Berardi D, Ruggeri M, Lasalvia A, Ferraro L, La Cascia C, La Barbera D, Menezes PR, Del-Ben CM; EU-GEI WP2 Group; Rutten BP, van Os J, Jones PB, Murray RM, Kirkbride JB, Morgan C. Gayer-Anderson C, et al. Among authors: de haan l. Soc Psychiatry Psychiatr Epidemiol. 2020 May;55(5):645-657. doi: 10.1007/s00127-020-01831-x. Epub 2020 Jan 23. Soc Psychiatry Psychiatr Epidemiol. 2020. PMID: 31974809 Free article.

2

Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH. Velthorst E, et al. Among authors: de haan l. Schizophr Res. 2009 Apr;109(1-3):60-5. doi: 10.1016/j.schres.2009.02.002. Epub 2009 Mar 9. Schizophr Res. 2009. PMID: 19272756

3

Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms.

Boyette L, Swets M, Meijer C, Wouters L; GROUP Authors. Boyette L, et al. Psychiatry Res. 2011 Apr 30;186(2-3):409-13. doi: 10.1016/j.psychres.2010.07.048. Epub 2010 Aug 30. Psychiatry Res. 2011. PMID: 20800902 Free article.

4

Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls.

Derks EM, Allardyce J, Boks MP, Vermunt JK, Hijman R, Ophoff RA; GROUP. Derks EM, et al. Schizophr Bull. 2012 May;38(3):495-505. doi: 10.1093/schbul/sbq103. Epub 2010 Sep 23. Schizophr Bull. 2012. PMID: 20864620 Free PMC article.

5

Disability in people clinically at high risk of psychosis.

Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Velthorst E, et al. Among authors: de haan l. Br J Psychiatry. 2010 Oct;197(4):278-84. doi: 10.1192/bjp.bp.109.075036. Br J Psychiatry. 2010. PMID: 20884950

6

Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.

Lataster J, van Os J, de Haan L, Thewissen V, Bak M, Lataster T, Lardinois M, Delespaul PA, Myin-Germeys I. Lataster J, et al. Among authors: de haan l. J Clin Psychiatry. 2011 Oct;72(10):1397-404. doi: 10.4088/JCP.09m05466yel. J Clin Psychiatry. 2011. PMID: 21208588

7

Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients.

Buizer-Voskamp JE, Muntjewerff JW; Genetic Risk and Outcome in Psychosis (GROUP) Consortium Members; Strengman E, Sabatti C, Stefansson H, Vorstman JA, Ophoff RA. Buizer-Voskamp JE, et al. Biol Psychiatry. 2011 Oct 1;70(7):655-62. doi: 10.1016/j.biopsych.2011.02.015. Epub 2011 Apr 13. Biol Psychiatry. 2011. PMID: 21489405 Free PMC article.

8

Social cognitive impairments and psychotic symptoms: what is the nature of their association?

Fett AK, Maat A; GROUP Investigators. Fett AK, et al. Schizophr Bull. 2013 Jan;39(1):77-85. doi: 10.1093/schbul/sbr058. Epub 2011 Jun 22. Schizophr Bull. 2013. PMID: 21697150 Free PMC article.

9

Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up.

Velthorst E, Nieman DH, Meijer C, Linszen D, de Haan L. Velthorst E, et al. Among authors: de haan l. J Nerv Ment Dis. 2011 Jul;199(7):510-2. doi: 10.1097/NMD.0b013e3182214469. J Nerv Ment Dis. 2011. PMID: 21716066

10

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.

Machielsen M, Beduin AS, Dekker N; Genetic Risk and Outcome of Psychosis (GROUP) investigators; Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Machielsen M, et al. Among authors: de haan l. J Psychopharmacol. 2012 Jan;26(1):189-95. doi: 10.1177/0269881111408957. Epub 2011 Jul 18. J Psychopharmacol. 2012. PMID: 21768161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

888 results

Search Page